Inaugural Perspectives in Digestive Diseases 2018

Inaugural Perspectives in Digestive Diseases is organized by Global Academy for Medical Education and will be held during Apr 27 - 28, 2018 at Aria Resort and Casino, Las Vegas, Nevada, United States of America.

The target audience for this medical event is Gastroenterologists, Family Physicians, Internal Medicine Specialists, Nurse Practitioners, Physician Assistants, Registered Nurses, Nurses. This CME Conference has been approved for a maximum of 15 AMA PRA Category 1 Credits.

Conference Description:
In this conference, we explore the latest advances in the treatment and management of gastroenterological diseases. This conference is an opportunity to catch up on new developments in this complex area of medicine. Leading experts will present clinically relevant information that you will find im­mediately useful in the care of your patients.

We explore GERD, the spectrum of chronic viral hepatitis, Barrett’s oesophagus, fatty liver diseases, peptic ulcers, gastroparesis, complicated liver disease, colorectal screening and much more. Don’t miss our highly animated clinical case session. The format is interactive, informal and re­laxed, encouraging a free-flowing exchange of ideas and practical solutions for the busy clinician.

Conference Objectives:
• Explain the diagnosis and treatment strategies for GERD.
• Analyze and evaluate the most important new developments in Eosinophilic Esophagitis.
• Define Barrett’s esophagus and implement the appropriate treatment plan to achieve the desired clinical outcome.
• Explain the epidemiology, mechanisms and management of gastroparesis.
• Compare and contrast the various types of peptic ulcers.
• Describe the most current colorectal cancer screening guidelines and recommendations.
• Describe the risk factors for and clinical presentation of celiac disease.
• Discuss how therapeutic manipulation of the microbiota may represent a novel means to prevent and treat GI diseases.
• Discuss state-of-the art diagnostic treatment guidelines for Hepatitis B and C.
• Formulate strategies for preventing, diagnosing, treating and/or referring patients with Hepatitis B and C.
• Describe how to diagnose and manage fatty liver disease.
• Recognize and treat autoimmune hepatitis and maximize treatment outcomes.
• Discuss the current therapies for primary biliary cholangitis and strategies to improve management.
• Review new concepts in the management of complications of end stage liver disease.
• Develop individualized treatment plans for patients with irritable bowel syndrome according to the characteristics and severity of their symptoms.
• Differentiate irritable bowel syndrome (IBS) from other common gastrointestinal disorders.
• Describe new and emerging management strategies for IBS including therapeutic options, diet changes and other alternatives.
• Define, diagnose and treat anorectal disorders.
• Assess and select treatment plans for patients with opioid-induced constipation.
• Identify treatment options for the management of Crohn’s disease.
• Review the mechanisms of action available and emerging therapeutic agents for the management of moderate-to-severe ulcerative colitis.
• Summarize appropriate irritable bowel disease management strategies for special patient populations.
• Explain current and emerging therapies in liver lesions.
• Describe an abnormal liver panel and develop an approach to their evaluation.
• Detect when to refer a patient for liver transplantation evaluation.
• Describe optimal dosing strategies for colonoscopy prep to improve detection and colon cancer prevention.